Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Country's Decision or any other Communication
(DEC)
last updated: 14 Apr 2020
No
KEMENTAN RI No. I. 19106070 VKC PRG
EN
29 Oct 2019
No
- Decision on LMOs for intentional introduction into the environment (according to Article 10 or domestic regulatory framework)
- Decision taken in accordance with your domestic regulatory framework
Yes
-
Person:DVM, Ph.D. Robin Dalgleish (Griff)Intervet International BV Wim de KÖrverstraat 35 P.O. BOX 31 5830 AA Boxmeer - The NetherlandsBoxmeer,
, Netherlands (Kingdom of the)Phone: +31 485 58 7600,Fax:Email: grabiolicensing@merck.com,Website:Related OrganizationExecutive Director Regulatory Affairs, Asia Pacific ()Non-governmental organization (NGO)Intervet International BV Wim de KÖrverstraat 35 P.O. BOX 31 5830 AA Boxmeer - The NetherlandsBoxmeer,
, Netherlands (Kingdom of the)Phone: +31 485 58 7600,Fax:Email: grabiolicensing@merck.com,Website:
-
Person:DVM Khalida NoorAssociate Director Regulatory Affairs, ID-MY-SG, Associate Directore Regulatory AffairsWisma BNI 46 27th Floor Jl. jenderal sudirman Kav. 1 Jakarta Pusat 10220, Indonesiajakarta,
, IndonesiaPhone: +622157897000,Fax:Email: khalida.noor@merck.com,Website:Related OrganizationPT. Intervet Indonesia ()Private sector (business and industry)Wisma BNI 46 27th Floor Jl. jenderal sudirman Kav. 1 Jakarta Pusat 10220, Indonesiajakarta,
, IndonesiaPhone: +622157897000,Fax:Email: khalida.noor@merck.com,Website:
No
Yes
Yes
Approval of the import and/or use of the LMO(s) without conditions
-
BCH-LMO-SCBD-105091-1 Living Modified Organism INNOVAX® ND VaccineIntervet do Brasil Veterinária Ltda(INTERVET) | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
-
BCH-RA-ID-115498-1 Risk Assessment generated by a regulatory process Summary of GMO product environmental risk assessment Nobilis® rHVT-ND (Innovax®-ND)INNOVAX® ND Vaccine | Production of medical or pharmaceutical compounds (human or animal)
- nationalrecord_05_decisions_en - INNOVAX-ND.DOC [ English ]